Alyeska Investment Group’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.36M | Buy |
217,113
+75,000
| +53% | +$2.2M | 0.02% | 394 |
|
|
2025
Q1 | $3.65M | Hold |
142,113
| – | – | 0.01% | 378 |
|
|
2024
Q4 | $4.1M | Buy |
142,113
+20,000
| +16% | +$577K | 0.02% | 408 |
|
|
2024
Q3 | $2.9M | Sell |
122,113
-199,602
| -62% | -$4.74M | 0.01% | 391 |
|
|
2024
Q2 | $5.56M | Buy |
321,715
+122,113
| +61% | +$2.11M | 0.03% | 322 |
|
|
2024
Q1 | $4.43M | Buy |
+199,602
| New | +$4.43M | 0.03% | 327 |
|
|
2021
Q3 | – | Sell |
-4,286
| Closed | -$922K | – | 814 |
|
|
2021
Q2 | $922K | Buy |
+4,286
| New | +$922K | 0.01% | 614 |
|